Goodrx Holdings - Class A (GDRX) closed at $3.65 on November 11, 2026, up 3.1% from the previous close, on volume of 829,707 shares (30-day average 1,039,077).
Data as of November 11, 2026.
GoodRx becomes launch partner for Google Cloud’s Gemini for healthcare
Seeking Alpha News (Tue, 10-Nov 8:45 AM ET)
GoodRx Brings Prescription Pricing Intelligence to Google Cloud's Gemini for Healthcare
Business Wire (Tue, 10-Nov 8:05 AM ET)
GoodRx Holdings Delays Third-Quarter Report Filing Amid Restatement Work
TipRanks (Tue, 10-Nov 7:17 AM ET)
GoodRx Launches Employer Direct Weight Loss Offering
Business Wire (Thu, 29-Oct 9:15 AM ET)
Business Wire (Thu, 3-Sep 9:00 AM ET)
GoodRx’s Pharma Direct and Subscription Growth Offsets Transaction Revenue Decline as Guidance Rises
Market Chameleon (Thu, 6-Aug 7:21 AM ET)
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Goodrx Holdings - Class A trades on the NASDAQ stock market under the symbol GDRX.
As of November 12, 2026, GDRX stock price declined to $3.51 with 691,170 million shares trading.
GDRX has a beta of 1.98, meaning it tends to be more sensitive to market movements. GDRX has a correlation of 0.16 to the broad based SPY ETF.
GDRX has a market cap of $1.19 billion. This is considered a Small Cap stock.
Last quarter Goodrx Holdings - Class A reported $200 million in Revenue and $.08 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.01.
In the last 3 years, GDRX traded as high as $9.26 and as low as $1.77.
The top ETF exchange traded funds that GDRX belongs to (by Net Assets): VTI, DFSV, VXF, VB, DFAT.
GDRX has outperformed the market in the last year with a price return of +15.8% while the SPY ETF gained +12.0%. However, in the short term, GDRX had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.6% vs -1.5% return in SPY. But in the last 2 weeks, GDRX shares have fared better than the market returning +1.2% compared to SPY -2.0%.
GDRX support price is $3.54 and resistance is $3.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GDRX shares will trade within this expected range on the day.
